AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
2
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
3
Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers
4
Salesforce seals $1.9 billion cash deal to acquire cloud backup company Own
5
Prompt Security raises $18 million Series A to protect enterprises from GenAI risks
More news

FDA

15 stories about FDA
הילה גולדמן אצלאן דיא ניתוח הדמיות DIA

Medical Analytics Company DiA Imaging Raises $5 Million

08.08.18|CTech
DiA develops a medical imaging analysis software based on pattern recognition and machine learning algorithms
הטכנולוגיה של Healthy.io

Mobile Phone Urine Testing Kit Receives FDA Approval

26.07.18|Tofi Stoler
Developed by Tel Aviv-based Healthy.io, the technology uses computer vision algorithms, artificial intelligence, and a smartphone’s built-in camera to run lab-standard urine tests
דוד גולן Viz.ai

Kleiner Perkins, Alphabet Back Stroke Detection Startup Viz.ai

18.07.18|Meir Orbach
Kleiner Perkins led a $21 million round for the medical startup. Viz.ai develops an automated analysis of brain scans
זקן כיסא גלגלים ביטוח בריאות ביטוח סיעודי

Following FDA Clearance, BioSight to Launch Clinical Trial for Treatment of Leukemia

15.07.18|CTech
The company’s compound will be administered to patients unfit for standard chemotherapy
רון בנצור

Sustained Drug Release Company UroGen Submits New Drug Application to FDA

12.07.18|Amir Rosenbaum
Kite Pharma founder Arie Belldegrun is the chairman of Israel-based UroGen, which focuses mainly on cancer treatment and urinary tract infections
אננס אננסים

MediWound’s Pineapple-Based Burn Treatment to Treat Mustard Gas Burns

31.05.18|Dror Reich
The Nasdaq-listed, Israeli based company received the FDA’s approval to expand the use of flagship burn treatment NexoBrid to those suffering from Sulfur Mustard injuries
מצפה רמון אסטרונאוטים d-mars

CTech's Tuesday Roundup of Israeli Tech News

24.04.18|CTech
The challenges of living on Mars: air, water, lack of personal space. Israeli lawmaker’s Twitter account suspended after tweet saying Palestinian girl in custody should have been shot
דוד גולן Viz.ai

AI Healthcare Company Viz.ai Receives FDA Clearance for Stroke Detection Technology

23.04.18|Hagar Ravet
Viz.ai develops deep learning and AI-powered technology that can analyze brain scans and automatically transfer pertinent data to a physician to ensure the most immediate treatment for strokes
rewalk רובוטיקה שלד חיצוני

ReWalk Launches Clinical Trials for Robotic Physical Rehab Suit

04.04.18|Asaf Shalev
After the conclusion of the 40-person trial, the company will seek clearance from U.S. and European regulators
ילד חולה ילדים חולים

Israeli Telehealth Startup Tyto Care Raises $21 Million

28.01.18|Meir Orbach
Tyto Care develops a digital stethoscope for remote medical testing and diagnosis
default image

Kite Pharma’s Cancer Drug Gets Regulatory Nod

19.10.17|Lilach Baumer
The cancer-treatment company, bought by Gilead Science in August for $11.9 billion, will sell one treatment course of the drug for $373,000
יצחק פטרבורג

Teva Submits Potential Moneymaker Migraine Drug for FDA Approval

18.10.17|Dror Reich and Lilach Baumer
Teva’s patent for its moneymaker multiple sclerosis drug Copaxone expired last year
חברת ה תרופות טבע Teva

Teva’s Stock Drops After Approval of Copaxone Competitors

08.10.17|Lilach Baumer
A day after Mylan announced FDA approval for its generic versions of Copaxone, drug companies Synthon and Alvogen announce European approval for their 40 mg/ml generic versions of Teva's blockbuster drug
default image

Teva Loses Copaxone Market Exclusivity

04.10.17|Lilach Baumer
Rival Mylan received FDA approval for its generic versions of Copaxone, Teva’s flagship drug
עמיר לונדון מנכ"ל קמהדע

Developer Of Anti-Rabies Drug Jumps on FDA Approval

27.08.17|Dror Reich
The plasma-derived drug is used together with the rabies vaccine to treat unvaccinated persons exposed to the virus
Previous Articles